Table of Content

1 Psoriasis and Atopic Dermatitis Drugs Market Introduction and Overview
1.1 Psoriasis and Atopic Dermatitis Drugs Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Psoriasis and Atopic Dermatitis Drugs Industry Dynamic Analysis
1.5.1 Psoriasis and Atopic Dermatitis Drugs Market Trends Analysis
1.5.2 Psoriasis and Atopic Dermatitis Drugs Market Drivers Analysis
1.5.3 Psoriasis and Atopic Dermatitis Drugs Market Challenges Analysis
1.5.4 Psoriasis and Atopic Dermatitis Drugs Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Psoriasis and Atopic Dermatitis Drugs Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Psoriasis and Atopic Dermatitis Drugs Revenue and Share by Type
3 Global Psoriasis and Atopic Dermatitis Drugs Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Psoriasis and Atopic Dermatitis Drugs Revenue and Share by Application (2019-2024)
4 Global Market Growth Insights
4.1 Global Psoriasis and Atopic Dermatitis Drugs Market Size (2019-2024)
4.2 Psoriasis and Atopic Dermatitis Drugs Growth Insights by Regions
4.2.1 Psoriasis and Atopic Dermatitis Drugs Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Psoriasis and Atopic Dermatitis Drugs Revenue Market Size by Regions (2019-2024)
4.2.3 North America Psoriasis and Atopic Dermatitis Drugs Market Size (2019-2024)
4.2.4 Europe Psoriasis and Atopic Dermatitis Drugs Market Size (2019-2024)
4.2.5 Asia-Pacific Psoriasis and Atopic Dermatitis Drugs Market Size (2019-2024)
4.2.6 Latin America Psoriasis and Atopic Dermatitis Drugs Market Size (2019-2024)
4.2.7 Middle East & Africa Psoriasis and Atopic Dermatitis Drugs Market Size (2019-2024)
5 North America
5.1 North America Psoriasis and Atopic Dermatitis Drugs Revenue by Countries
5.1.1 North America Psoriasis and Atopic Dermatitis Drugs Revenue by Countries (2019-2024)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Psoriasis and Atopic Dermatitis Drugs Revenue by Countries
6.1.1 Asia Pacific Psoriasis and Atopic Dermatitis Drugs Revenue by Countries (2019-2024)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Psoriasis and Atopic Dermatitis Drugs Revenue by Countries
7.1.1 Europe Psoriasis and Atopic Dermatitis Drugs Revenue by Countries (2019-2024)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Psoriasis and Atopic Dermatitis Drugs Revenue by Countries
8.1.1 Latin America Psoriasis and Atopic Dermatitis Drugs Revenue by Countries (2019-2024)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Psoriasis and Atopic Dermatitis Drugs Revenue by Countries
9.1.1 Middle East & Africa Psoriasis and Atopic Dermatitis Drugs Revenue by Countries (2019-2024)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Psoriasis and Atopic Dermatitis Drugs Market Competition, by Players
10.1 Global Psoriasis and Atopic Dermatitis Drugs Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Psoriasis and Atopic Dermatitis Drugs Players Market Share in 2023
10.2.2 Top 6 Psoriasis and Atopic Dermatitis Drugs Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Psoriasis and Atopic Dermatitis Drugs Players Head Office, Business Provided
10.4 Psoriasis and Atopic Dermatitis Drugs Mergers & Acquisitions
10.5 Psoriasis and Atopic Dermatitis Drugs New Entrants and Expansion Plans
11 Players Profiles
11.1 Leo Pharma
11.1.1 Leo Pharma Company Profile
11.1.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.1.3 Leo Pharma Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.1.4 Leo Pharma Business Overview
11.1.5 Recent Developments and Plans
11.2 Novartis International AG
11.2.1 Novartis International AG Company Profile
11.2.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.2.3 Novartis International AG Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.2.4 Novartis International AG Business Overview
11.2.5 Recent Developments and Plans
11.3 Mylan
11.3.1 Mylan Company Profile
11.3.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.3.3 Mylan Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.3.4 Mylan Business Overview
11.3.5 Recent Developments and Plans
11.4 Sanofi
11.4.1 Sanofi Company Profile
11.4.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.4.3 Sanofi Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.4.4 Sanofi Business Overview
11.4.5 Recent Developments and Plans
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Profile
11.5.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.5.3 Bristol-Myers Squibb Company Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.5.4 Bristol-Myers Squibb Company Business Overview
11.5.5 Recent Developments and Plans
11.6 Anacor Pharmaceutical Inc.
11.6.1 Anacor Pharmaceutical Inc. Company Profile
11.6.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.6.3 Anacor Pharmaceutical Inc. Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.6.4 Anacor Pharmaceutical Inc. Business Overview
11.6.5 Recent Developments and Plans
11.7 Encore Dermatology
11.7.1 Encore Dermatology Company Profile
11.7.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.7.3 Encore Dermatology Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.7.4 Encore Dermatology Business Overview
11.7.5 Recent Developments and Plans
11.8 Allergan Plc
11.8.1 Allergan Plc Company Profile
11.8.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.8.3 Allergan Plc Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.8.4 Allergan Plc Business Overview
11.8.5 Recent Developments and Plans
11.9 Regeneron Pharmaceuticals, Inc.
11.9.1 Regeneron Pharmaceuticals, Inc. Company Profile
11.9.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.9.3 Regeneron Pharmaceuticals, Inc. Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.9.4 Regeneron Pharmaceuticals, Inc. Business Overview
11.9.5 Recent Developments and Plans
11.10 Incyte
11.10.1 Incyte Company Profile
11.10.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.10.3 Incyte Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.10.4 Incyte Business Overview
11.10.5 Recent Developments and Plans
11.11 Pfizer
11.11.1 Pfizer Company Profile
11.11.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.11.3 Pfizer Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.11.4 Pfizer Business Overview
11.11.5 Recent Developments and Plans
11.12 Astellas Pharma, Inc.
11.12.1 Astellas Pharma, Inc. Company Profile
11.12.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
11.12.3 Astellas Pharma, Inc. Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
11.12.4 Astellas Pharma, Inc. Business Overview
11.12.5 Recent Developments and Plans
12 Global Psoriasis and Atopic Dermatitis Drugs Forecast Market Insights by Type
12.1 Global Psoriasis and Atopic Dermatitis Drugs Revenue Market Forecast by Type (2024-2030)
13 Global Psoriasis and Atopic Dermatitis Drugs Forecast Market Insights by Application
13.1 Psoriasis and Atopic Dermatitis Drugs Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Insights
14.1 Global Psoriasis and Atopic Dermatitis Drugs Forecast Market Size (2024-2030)
14.2 Psoriasis and Atopic Dermatitis Drugs Growth Forecast Insights by Regions
14.2.1 Psoriasis and Atopic Dermatitis Drugs Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Psoriasis and Atopic Dermatitis Drugs Forecast Market Size (2024-2030)
14.2.3 Europe Psoriasis and Atopic Dermatitis Drugs Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Psoriasis and Atopic Dermatitis Drugs Forecast Market Size (2024-2030)
14.2.5 Latin America Psoriasis and Atopic Dermatitis Drugs Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Psoriasis and Atopic Dermatitis Drugs Forecast Market Size (2024-2030)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer